TWI348916B - A novel treatment tool for cancer: rna interference of bcas2 - Google Patents
A novel treatment tool for cancer: rna interference of bcas2Info
- Publication number
- TWI348916B TWI348916B TW097112076A TW97112076A TWI348916B TW I348916 B TWI348916 B TW I348916B TW 097112076 A TW097112076 A TW 097112076A TW 97112076 A TW97112076 A TW 97112076A TW I348916 B TWI348916 B TW I348916B
- Authority
- TW
- Taiwan
- Prior art keywords
- bcas2
- cancer
- treatment tool
- rna interference
- novel treatment
- Prior art date
Links
- 101150038783 BCAS2 gene Proteins 0.000 title 1
- 101100478189 Dictyostelium discoideum spf27 gene Proteins 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000009368 gene silencing by RNA Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/062,478 US7718631B2 (en) | 2008-04-03 | 2008-04-03 | Treatment tool for cancer: RNA interference of BCAS2 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200942264A TW200942264A (en) | 2009-10-16 |
TWI348916B true TWI348916B (en) | 2011-09-21 |
Family
ID=39742257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW097112076A TWI348916B (en) | 2008-04-03 | 2008-04-02 | A novel treatment tool for cancer: rna interference of bcas2 |
Country Status (2)
Country | Link |
---|---|
US (1) | US7718631B2 (zh) |
TW (1) | TWI348916B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110387424A (zh) * | 2019-07-12 | 2019-10-29 | 安徽农业大学 | Bcas2基因用于判断圩公猪初情期启动时间的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002044321A2 (en) * | 2000-12-01 | 2002-06-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Rna interference mediating small rna molecules |
DK2284266T3 (da) * | 2002-11-14 | 2014-01-13 | Thermo Fisher Scient Biosciences Inc | sIRNA-MOLEKYLE MOD TP53 |
US20070009899A1 (en) * | 2003-10-02 | 2007-01-11 | Mounts William M | Nucleic acid arrays for detecting gene expression in animal models of inflammatory diseases |
-
2008
- 2008-04-02 TW TW097112076A patent/TWI348916B/zh not_active IP Right Cessation
- 2008-04-03 US US12/062,478 patent/US7718631B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7718631B2 (en) | 2010-05-18 |
TW200942264A (en) | 2009-10-16 |
US20080221059A1 (en) | 2008-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1200363A1 (zh) | 用於治療癌症的化合物 | |
IL229878A (en) | Cancer Treatment Compounds | |
EP2470534A4 (en) | INHIBITION OF JAK BLOCKES TOXICITIES ASSOCIATED WITH INTERFERENCE RNA | |
EP2205072A4 (en) | METHODS OF TREATING DIFFERENT DISEASES AND CONDITIONS, AND COMPOUNDS USED THEREOF | |
EP1987838A4 (en) | NEW CONNECTION TO TUMOR THERAPY | |
IL213398A0 (en) | Compounds for treating cancer | |
PT2957292T (pt) | Terapia de vitiligo | |
EP2478860A4 (en) | HIGH FREQUENCY TREATMENT INSTRUMENT | |
HK1126182A1 (en) | Process for synthesizing sevoflurance | |
IL210066A0 (en) | Novel ortho-aminoanilides for the treatment of cancer | |
EP1986656A4 (en) | WITHACNISTINE COMPOUNDS FOR THE TREATMENT OF CANCER | |
EP2028181A4 (en) | PROCESS FOR PRODUCING GLYCIDOL | |
ZA201000670B (en) | Process for producing toluidine compound | |
EP2250290A4 (en) | PTTG1 AS A BIOMARKER FOR CANCER TREATMENT | |
TWI348916B (en) | A novel treatment tool for cancer: rna interference of bcas2 | |
EP2214485A4 (en) | METHOD FOR THE TREATMENT OF CANCER | |
GB0914322D0 (en) | Compounds for treating cancer | |
GB0901794D0 (en) | Compounds for treating muscular dystrophy | |
AU2008903467A0 (en) | A method of treatment | |
AU2008903444A0 (en) | A method of treatment | |
AU2008902088A0 (en) | A method of treatment | |
IL193470A0 (en) | Process for preparing of 2-alkyl-3-aryl-prop-2- ene-1-ols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |